ReposiTrak Net Worth
ReposiTrak Net Worth Breakdown | TRAK |
ReposiTrak Net Worth Analysis
ReposiTrak's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including ReposiTrak's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of ReposiTrak's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform ReposiTrak's net worth analysis. One common approach is to calculate ReposiTrak's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares ReposiTrak's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing ReposiTrak's net worth. This approach calculates the present value of ReposiTrak's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of ReposiTrak's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate ReposiTrak's net worth. This involves comparing ReposiTrak's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into ReposiTrak's net worth relative to its peers.
Enterprise Value |
|
To determine if ReposiTrak is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding ReposiTrak's net worth research are outlined below:
ReposiTrak is unlikely to experience financial distress in the next 2 years | |
ReposiTrak currently holds 481.02 K in liabilities with Debt to Equity (D/E) ratio of 0.83, which is about average as compared to similar companies. ReposiTrak has a current ratio of 0.88, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about ReposiTrak's use of debt, we should always consider it together with its cash and equity. | |
About 36.0% of ReposiTrak outstanding shares are owned by corporate insiders | |
On 13th of November 2024 ReposiTrak paid 0.0165 per share dividend to its current shareholders | |
Latest headline from benzinga.com: Chief Executive Officer At ReposiTrak Sells 172K Of Stock |
ReposiTrak Quarterly Good Will |
|
ReposiTrak uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in ReposiTrak. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ReposiTrak's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
13th of February 2024 Upcoming Quarterly Report | View | |
31st of December 2023 Next Fiscal Quarter End | View |
Know ReposiTrak's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as ReposiTrak is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ReposiTrak backward and forwards among themselves. ReposiTrak's institutional investor refers to the entity that pools money to purchase ReposiTrak's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Northern Trust Corp | 2024-09-30 | 95.6 K | Goss Wealth Management Llc | 2024-09-30 | 93.3 K | O'shaughnessy Asset Management Llc | 2024-09-30 | 71.4 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 70.2 K | Eam Investors, Llc | 2024-09-30 | 68.1 K | Bridgeway Capital Management, Llc | 2024-09-30 | 41.5 K | Thompson Davis & Co Inc | 2024-09-30 | 37.7 K | Comprehensive Portfolio Management, Llc | 2024-09-30 | 37.6 K | Charles Schwab Investment Management Inc | 2024-09-30 | 34 K | Handelsbanken Fonder Ab | 2024-09-30 | 1.4 M | Rice Hall James & Associates, Llc | 2024-09-30 | 1 M |
Follow ReposiTrak's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 391.2 M.Market Cap |
|
Project ReposiTrak's profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.20 | 0.21 | |
Return On Capital Employed | 0.11 | 0.11 | |
Return On Assets | 0.12 | 0.12 | |
Return On Equity | 0.13 | 0.13 |
When accessing ReposiTrak's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures ReposiTrak's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of ReposiTrak's profitability and make more informed investment decisions.
Evaluate ReposiTrak's management efficiency
ReposiTrak has return on total asset (ROA) of 0.0615 % which means that it generated a profit of $0.0615 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1285 %, meaning that it created $0.1285 on every $100 dollars invested by stockholders. ReposiTrak's management efficiency ratios could be used to measure how well ReposiTrak manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is expected to rise to 0.21 this year. Return On Capital Employed is expected to rise to 0.11 this year. At this time, ReposiTrak's Total Current Liabilities is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 54.2 M this year, although the value of Non Current Liabilities Total will most likely fall to about 189 K.Last Reported | Projected for Next Year | ||
Book Value Per Share | 2.57 | 1.50 | |
Tangible Book Value Per Share | 1.40 | 1.47 | |
Enterprise Value Over EBITDA | 34.38 | 36.10 | |
Price Book Value Ratio | 6.11 | 6.34 | |
Enterprise Value Multiple | 34.38 | 36.10 | |
Price Fair Value | 6.11 | 6.34 | |
Enterprise Value | 80.8 M | 76.7 M |
Evaluating the management effectiveness of ReposiTrak allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The ReposiTrak Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Enterprise Value Revenue 18.9329 | Revenue 20.5 M | Quarterly Revenue Growth 0.079 | Revenue Per Share 1.124 | Return On Equity 0.1285 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ReposiTrak insiders, such as employees or executives, is commonly permitted as long as it does not rely on ReposiTrak's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ReposiTrak insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
ReposiTrak Corporate Filings
F4 | 26th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 20th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 14th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
13th of November 2024 Other Reports | ViewVerify |
ReposiTrak Earnings per Share Projection vs Actual
ReposiTrak Corporate Management
Joe Meherg | Senior Sales | Profile | |
Derek Hannum | Chief Officer | Profile | |
Edward Clissold | General Secretary | Profile | |
John Merrill | Chief Officer | Profile | |
Jozef Jamrich | Chief Officer | Profile | |
Rob Fink | Investor Professional | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ReposiTrak. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy ReposiTrak Stock please use our How to buy in ReposiTrak Stock guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ReposiTrak. If investors know ReposiTrak will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ReposiTrak listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.195 | Dividend Share 0.065 | Earnings Share 0.29 | Revenue Per Share 1.124 | Quarterly Revenue Growth 0.079 |
The market value of ReposiTrak is measured differently than its book value, which is the value of ReposiTrak that is recorded on the company's balance sheet. Investors also form their own opinion of ReposiTrak's value that differs from its market value or its book value, called intrinsic value, which is ReposiTrak's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ReposiTrak's market value can be influenced by many factors that don't directly affect ReposiTrak's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ReposiTrak's value and its price as these two are different measures arrived at by different means. Investors typically determine if ReposiTrak is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ReposiTrak's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.